Form 4 for CRL Charles River Laboratories
Accepted 2024-05-31 00:00:00 ET · period of report 2024-05-29 · accession 0001127602-24-017116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-31 | 2024-05-29 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $214.51 | -223 | 22.5K | -1.0% | -$47.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-29 | F | D | 223 | $214.51 | 22,501 | D | — | — |